Some antiamyloids remove target plaques from the brain, yet don’t seem to halt cognitive decline. Researchers are working to understand why.
The Search for a Drug to End Alzheimer’s (Links to an external site)
Category: News
Aiming at the Tangle’s Heart? DIAN-TU Trial to Torpedo Tau’s Core (Links to an external site)
Encouraging findings in Alzheimer’s prevention trial lead to the next phase (Links to an external site)
International Alzheimer’s clinical trial to test tau drugs (Links to an external site)
Bateman, Diamond, Hultgren named to National Academy of Inventors (Links to an external site)
School of Medicine scientists honored for innovation
Dementia First blood test to help diagnose Alzheimer’s goes on sale (Links to an external site)
Barch, Bateman elected to National Academy of Medicine (Links to an external site)
AAIC 2020, dallo studio DIAN-TU la terapia contro l’Alzheimer (Links to an external site)
Elixir Factor Podcast S2 Ep6: Dominantly Inherited Alzheimer’s Disease: A View From Within (Links to an external site)
Gantenerumab improved markers of disease in rare, inherited form of Alzheimer’s disease
Further analysis of data from an international trial of two investigational drugs in people in the early stages of a rare, inherited form of Alzheimer’s disease has demonstrated that one of the drugs had a positive impact on biomarkers of the disease. The study (ClinicalTrials.gov Identifier: NCT01760005) is a phase 2/3 trial led by Washington […]